Genetic and shared environmental risk factors do not lead to eosinophil activation in healthy twins of IBD patients
暂无分享,去创建一个
[1] V. Apostolopoulos,et al. Eosinophils in Inflammatory Bowel Disease. , 2019, Inflammatory bowel diseases.
[2] S. Mathur,et al. Comparison of IL-33 and IL-5 family mediated activation of human eosinophils , 2019, bioRxiv.
[3] K. Papadakis,et al. Mechanisms of Disease: Inflammatory Bowel Diseases. , 2019, Mayo Clinic proceedings.
[4] C. Lindqvist,et al. Gut Barrier Dysfunction—A Primary Defect in Twins with Crohn’s Disease Predominantly Caused by Genetic Predisposition , 2018, Journal of Crohn's & colitis.
[5] P. Rutgeerts,et al. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease. , 2016, Journal of Crohn's & colitis.
[6] M. Dubinsky,et al. Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities , 2016, Gut.
[7] Y. Kinoshita,et al. The Number and Distribution of Eosinophils in the Adult Human Gastrointestinal Tract: A Study and Comparison of Racial and Environmental Factors , 2015, The American journal of surgical pathology.
[8] Paige Lacy,et al. Eosinophil Cytokines, Chemokines, and Growth Factors: Emerging Roles in Immunity , 2014, Front. Immunol..
[9] L. Bodin,et al. Subclinical Inflammation with Increased Neutrophil Activity in Healthy Twin Siblings Reflect Environmental Influence in the Pathogenesis of Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.
[10] M. Johannesson,et al. The Swedish Twin Registry: Establishment of a Biobank and Other Recent Developments , 2012, Twin Research and Human Genetics.
[11] B. Monsarrat,et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G , 2012, Proceedings of the National Academy of Sciences.
[12] J. Söderholm,et al. Importance of disrupted intestinal barrier in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.
[13] Anders F. Andersson,et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.
[14] P. Venge. The eosinophil and airway remodelling in asthma , 2010, The clinical respiratory journal.
[15] J. Ludvigsson,et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.
[16] Janet K. Jansson,et al. Twin studies reveal specific imbalances in the mucosa‐associated microbiota of patients with ileal Crohn's disease , 2009, Inflammatory bowel diseases.
[17] M. Rothenberg,et al. Biology of the eosinophil. , 2009, Advances in immunology.
[18] O. Winqvist,et al. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis , 2008, Journal of leukocyte biology.
[19] J. Jansson,et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease , 2008, The ISME Journal.
[20] M. Collins,et al. Quantity and Distribution of Eosinophils in the Gastrointestinal Tract of Children , 2006, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[21] John B Carlin,et al. Regression models for twin studies: a critical review. , 2005, International journal of epidemiology.
[22] J. Satsangi,et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[23] O. Winqvist,et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis , 2005, Gut.
[24] A. Duhamel,et al. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease , 2005, Gut.
[25] T. Bouchard,et al. Genetic and environmental influences on human psychological differences. , 2003, Journal of neurobiology.
[26] P. Lichtenstein,et al. The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies , 2002, Journal of internal medicine.
[27] Y. Raab,et al. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease , 2002, American Journal of Gastroenterology.
[28] A. Öst,et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis , 2000, Gut.
[29] P. Venge,et al. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion , 1999, American Journal of Gastroenterology.
[30] D G Altman,et al. Statistics Notes: The use of transformation when comparing two means , 1996, BMJ.
[31] M. Manns,et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease , 1996, Histopathology.
[32] Walter W. Piegorsch,et al. Design and analysis of reliability studies: The statistical evaluation of measurement errors. Graham Dunn, Oxford University Press, New York, 1989. No. of pages: ix + 198. Price: £25 , 1991 .
[33] Graham Dunn,et al. Design and Analysis of Reliability Studies: The Statistical Evaluation of Measurement Errors , 1989 .